Springer Nature
Browse
13048_2020_751_MOESM1_ESM.tif (871.18 kB)

Additional file 1 of Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report

Download (871.18 kB)
figure
posted on 2020-12-09, 07:29 authored by Yu-Chien Lin, Kuo-Chang Wen, Pi-Lin Sung, Yu-Ting Chou, Phui-Ly Liew, Lin-Yu Chen, Rui-Lan Huang, Hung-Cheng Lai, Lu-Te Chang
Additional file 1: Supplementary Figure 1. Immunohistochemistry (IHC) of the PD-L1 control. (a) Positive control of PD-L1 staining (Dako 22C3, tonsil). (b) Positive control of PD-L1 staining (Dako 28–8, tonsil)

Funding

Ministry of Science and Technology, Taiwan Taipei Medical University Teh-Tzer Study Group for Human Medical Research Foundation of Taiwan

History

Usage metrics

    Journal of Ovarian Research

    Categories

    Keywords

    Angiogenesis inhibitorARID1ACheckpoint inhibitorOvarian clear cell carcinoma

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC